Lack of association of OPRM1 genotype and smoking cessation.

Lack of association of OPRM1 genotype and smoking cessation.

<p>INTRODUCTION: Previous studies have reported an association between μ-opioid receptor (OPRM1) genotype and smoking cessation, with some evidence that the strength of this association depends on dose of nicotine replacement therapy (NRT). We examined whether a single-nucleotide polymorphism...

Descripció completa

Dades bibliogràfiques
Autors principals:	Munafò, MR, Johnstone, E, Aveyard, P, Marteau, T
Altres autors:	Society for Research on Nicotine and Tobacco
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2013

Ítems similars

Association of COMT Val108/158Met genotype with smoking cessation.
per: Munafò, MR, et al.
Publicat: (2008)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
per: Munafò, MR, et al.
Publicat: (2009)

CHRNA3 rs1051730 genotype and short-term smoking cessation.
per: Munafò, MR, et al.
Publicat: (2011)

Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
per: Munafo, M, et al.
Publicat: (2009)

Smoking cessation, weight gain, and DRD4 -521 genotype
per: Munafò, MR, et al.
Publicat: (2006)

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.
per: Spruell, T, et al.
Publicat: (2012)

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
per: David, S, et al.
Publicat: (2011)

Association of the mu-opioid receptor gene with smoking cessation.
per: Munafò, MR, et al.
Publicat: (2007)

Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial.
per: Johnstone, E, et al.
Publicat: (2007)

Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
per: Uhl, G, et al.
Publicat: (2010)

Effects of dopamine D2 receptor gene polymorphisms on smoking cessation: Abstinence and withdrawal symptoms
per: Munafo, MR, et al.
Publicat: (2007)

Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.
per: Aveyard, P, et al.
Publicat: (2007)

Interventions for smoking cessation in hospitalised patients
per: Rigotti, NA, et al.
Publicat: (2002)

Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
per: David, S, et al.
Publicat: (2008)

Erratum: Genome-wide association for smoking cessation success: Participants in the Patch in Practice trial of nicotine replacement (Pharmacogenomics (2010) 11:3 (357-367))
per: Uhl, G, et al.
Publicat: (2010)

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.
per: Welton, N, et al.
Publicat: (2008)

Smoking cessation 4: Antidepressants for smoking cessation - Bupropion and nortriptyline
per: Aveyard, P, et al.
Publicat: (2010)

Smoking reduction interventions for smoking cessation
per: Lindson, N, et al.
Publicat: (2018)

Managing smoking cessation.
per: Aveyard, P, et al.
Publicat: (2007)

Drugs for smoking cessation
per: Hartmann-Boyce, J, et al.
Publicat: (2016)

Interventions for smoking cessation in hospitalised patients
per: Rigotti, NA, et al.
Publicat: (2012)

Change in anxiety following successful and unsuccessful attempts at smoking cessation: cohort study.
per: McDermott, MS, et al.
Publicat: (2013)

Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
per: Aveyard, P, et al.
Publicat: (2009)

Financial incentives for smoking cessation in pregnancy: protocol for a single arm intervention study.
per: Marteau, T, et al.
Publicat: (2013)

Addressing concerns about smoking cessation and mental health: Theoretical review and practical guide for healthcare professionals
per: Taylor, GMJ, et al.
Publicat: (2020)

The place of varenicline in smoking cessation treatment.
per: Aveyard, P
Publicat: (2008)

Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
per: Munafò, MR, et al.
Publicat: (2008)

Smoking reduction interventions for smoking cessation
per: Lindson, N, et al.
Publicat: (2019)

Genes and cigarette smoking.
per: Munafò, MR, et al.
Publicat: (2008)

Lack of attentional retraining effects in cigarette smokers attempting cessation: A proof of concept double-blind randomised controlled trial
per: Begh, R, et al.
Publicat: (2015)

Smoking cessation interventions for hospitalized smokers: a systematic review.
per: Rigotti, N, et al.
Publicat: (2008)

Electronic cigarettes for smoking cessation
per: Hartmann-Boyce, J, et al.
Publicat: (2018)

Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.
per: Hollands, G, et al.
Publicat: (2013)

Investigating subgroups in smoking cessation treatment response: Response to Perkins
per: Munafo, MR, et al.
Publicat: (2004)

Motivational interviewing for smoking cessation
per: Lindson, N, et al.
Publicat: (2019)

Future orientation and smoking cessation: secondary analysis of data from a smoking cessation trial.
per: Beenstock, J, et al.
Publicat: (2014)

Improving smoking cessation approaches at the individual level.
per: Aveyard, P, et al.
Publicat: (2012)

Smoking cessation 1: Choosing the right pharmacotherapy for each patient
per: Aveyard, P, et al.
Publicat: (2009)

Managing smoking cessation Authors’ reply to letter
per: Aveyard, P, et al.
Publicat: (2007)

Association of OPRM1 with addiction: a review on drug, alcohol and smoking addiction in worldwide population
per: Vanlal Hriatpuii, et al.
Publicat: (2022-03-01)